Lon­za com­pletes Chi­na ex­pan­sion to sup­port HPA­PI pro­duc­tion

At the end of 2021, a re­port from CPhI named Lon­za among the CD­MO big dogs that will soon be re­spon­si­ble for more than half of the world’s man­u­fac­tur­ing ca­pac­i­ty by 2025. The Swiss com­pa­ny took an­oth­er step in that di­rec­tion Tues­day with the com­ple­tion of a Chi­nese ex­pan­sion.

Lon­za com­plet­ed the ex­pan­sion of its API de­vel­op­ment and man­u­fac­tur­ing labs at its Nan­sha, Chi­na, site. The move was fo­cused on ex­tend­ing the ca­pa­bil­i­ties of high po­ten­cy APIs, and ex­pand­ed man­u­fac­tur­ing space to en­sure that clin­i­cal sup­ply lev­els could meet de­mand.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER